Resource utilization and costs associated with the addition of an antimuscarinic in patients treated with an alpha-blocker for the treatment of urinary symptoms linked to benign prostatic hyperplasia

Resource utilization and costs associated with the addition of an antimuscarinic in patients treated with an alpha-blocker for the treatment of urinary symptoms linked to benign prostatic hyperplasia

Abstract Background There has been a change in the focus of attention from prostate to bladder, as the etiology of lower urinary tract symptoms (LUTS) makes the bladder an additional therapeutic target. This study aims to evaluate the use of resources and costs associated with the addition of an ant...

Full description

Bibliographic Details
Main Authors: Antoni Sicras-Mainar, Ruth Navarro-Artieda, Ana Mª. Mora, Marta Hernández
Format: Article
Language:English
Published: BMC 2017-09-01
Series:BMC Urology
Subjects:
Lower urinary tract symptoms
Benign prostatic hyperplasia
Antimuscarinics
Resource utilization
Costs
Online Access:http://link.springer.com/article/10.1186/s12894-017-0275-6

Internet

http://link.springer.com/article/10.1186/s12894-017-0275-6

Similar Items